insights_auto
Why is AVXL down 14,41%?
Dive Deeperchevron_right
AVXL:NASDAQ
Anavex Life Sciences Corp
2,02 $
arrow_downward
-14,41%(-0,34) 1D
2,05 $
arrow_upward
+1,48% (+0,030)bedtimeAfter hours
Closed: 30 սեպ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AVXL...
Open
2,38 $
High
2,38 $
Low
1,89 $
Mkt. cap
187,25 մլն
Avg. vol.
757,88 հզր
Volume
2,95 մլն
52-wk high
10,38 $
52-wk low
1,89 $
EPS
-0,15 $
Beta
1,14
Shares outstanding
92,70 մլն
No. of employees
34
Open
2,38 $
High
2,38 $
Low
1,89 $
Mkt. cap
187,25 մլն
Avg. vol.
757,88 հզր
Volume
2,95 մլն
52-wk high
10,38 $
52-wk low
1,89 $
EPS
-0,15 $
Beta
1,14
Shares outstanding
92,70 մլն
No. of employees
34
News stories
From web sources and news partners
PR Newswire
·
1 ժամ առաջ
AVXL Investors Have Opportunity to Lead Anavex Life Sciences Corp. Securities Fraud Lawsuit Filed by The Rosen Law Firm
Morningstar
·
4 ժամ առաջ
AVXL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Anavex (NASDAQ: AVXL) Investors of Securities Class Action Lawsuit Deadline on November 30, 2026
About Anavex Life Sciences Corp
CEOChristopher U. Missling Ph.D.
Employees34
Founded2004
HeadquartersՆյու Յորք, Նյու Յորք, Միացյալ Նահանգներ
Sector-
Websiteanavex.com